Obstructive sleep apnea syndrome and cardiovascular diseases

Seminars in Thrombosis and Hemostasis

Volumn 37, Issue 3, 2011, Pages 280-297

  Fava, Cristiano ^a,d   Montagnana, Martina ^a   Favaloro, Emmanuel J ^b   Guidi, Gian Cesare ^a   Lippi, Giuseppe ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d Section of Internal Medicine   (Italy)

Author keywords

acute myocardial infarction; cardiovascular disease; hypertension; Sleep apnea; stroke

Indexed keywords

ALLOPURINOL; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; ENDOTHELIN 1; GELATINASE B; HOMOCYSTEINE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANTHROPOMETRIC PARAMETERS; AROUSAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD CLOTTING DISORDER; BLOOD LEVEL; BLOOD PRESSURE MONITORING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CLINICAL STUDY; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FIBRINOLYSIS; GENETIC PREDISPOSITION; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE; HEART RATE; HEMODYNAMIC PARAMETERS; HERBST MANDIBULAR ADVANCEMENT SPLINT; HUMAN; HYPERCAPNIA; HYPERCOAGULABILITY; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXEMIA; INSULIN RESISTANCE; LEUKOCYTE; LUNG VOLUME; METABOLIC DISORDER; MICROAROUSAL; MUSCLE SYMPATHETIC NERVE ACTIVITY; NECK CIRCUMFERENCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; OXYGEN SATURATION; OXYGENATION; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SLEEP APNEA SYNDROME; SPLINT; STROKE; SYMPATHETIC FUNCTION; THORAX PRESSURE; THROMBOCYTE AGGREGATION; VASCULAR RESISTANCE; WAIST HIP RATIO;

ANIMALS; ANOXIA; AROUSAL; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HEART FAILURE; HUMANS; HYPERCAPNIA; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MYOCARDIAL ISCHEMIA; SLEEP APNEA, OBSTRUCTIVE; STROKE;

EID: 79953648261     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0031-1273092     Document Type: Article

References (310)

1. Punjabi N M. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008 5 2 136-143 (Pubitemid 351237871)
2. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993 328 17 1230-1235 (Pubitemid 23115702)
3. Ancoli-Israel S, Kripke D F., Klauber M R., Mason W J., Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep 1991 14 6 486-495
4. Newacheck P W., Taylor W R. Childhood chronic illness: prevalence, severity, and impact. Am J Public Health 1992 82 3 364-371
5. Guilleminault C, Lee J H., Chan A. Pediatric obstructive sleep apnea syndrome. Arch Pediatr Adolesc Med 2005 159 8 775-785 (Pubitemid 41126844)
6. Grunstein R, Wilcox I, Yang T S., Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 1993 17 9 533-540 (Pubitemid 23269132)
7. Wetter D W., Young T B., Bidwell T R., Badr M S., Palta M. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994 154 19 2219-2224 (Pubitemid 24317269)
8. Mitler M M., Dawson A, Henriksen S J., Sobers M, Bloom F E. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988 12 6 801-805 (Pubitemid 19018885)
9. Partinen M, Telakivi T. Epidemiology of obstructive sleep apnea syndrome. Sleep 1992 15 6, Suppl S1-S4 (Pubitemid 23004822)
10. Winkelman J W., Goldman H, Piscatelli N, Lukas S E., Dorsey C M., Cunningham S. Are thyroid function tests necessary in patients with suspected sleep apnea? Sleep 1996 19 10 790-793 (Pubitemid 27131929)
11. Grunstein R R., Ho K Y., Sullivan C E. Sleep apnea in acromegaly. Ann Intern Med 1991 115 7 527-532
12. Leiter J C., Knuth S L., Bartlett D Jr. The effect of sleep deprivation on activity of the genioglossus muscle. Am Rev Respir Dis 1985 132 6 1242-1245 (Pubitemid 16156380)
13. Liu P Y., Yee B, Wishart S M. et al. The short-term effects of high-dose testosterone on sleep, breathing, and function in older men. J Clin Endocrinol Metab 2003 88 8 3605-3613 (Pubitemid 37034502)
14. Redline S, Tishler P V. The genetics of sleep apnea. Sleep Med Rev 2000 4 6 583-602 (Pubitemid 32104353)
15. Sundquist J, Li X, Friberg D, Hemminki K, Sundquist K. Obstructive sleep apnea syndrome in siblings: an 8-year Swedish follow-up study. Sleep 2008 31 6 817-823 (Pubitemid 351810511)
16. Buxbaum S G., Elston R C., Tishler P V., Redline S. Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis. Genet Epidemiol 2002 22 3 243-253 (Pubitemid 34246664)
17. Gislason T, Johannsson J H., Haraldsson A et al. Familial predisposition and cosegregation analysis of adult obstructive sleep apnea and the sudden infant death syndrome. Am J Respir Crit Care Med 2002 166 6 833-838
18. Friberg D, Sundquist J, Li X, Hemminki K, Sundquist K. Sibling risk of pediatric obstructive sleep apnea syndrome and adenotonsillar hypertrophy. Sleep 2009 32 8 1077-1083
19. Yaggi H K., Concato J, Kernan W N., Lichtman J H., Brass L M., Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005 353 19 2034-2041 (Pubitemid 41609096)
20. Marshall N S., Wong K K., Liu P Y., Cullen S R., Knuiman M W., Grunstein R R. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008 31 8 1079-1085
21. McNicholas W T., Bonsigore M R., Bonsignore M R. Management Committee of EU COST ACTION B26. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007 29 1 156-178 (Pubitemid 46092013)
22. Somers V K., White D P., Amin R et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. J Am Coll Cardiol 2008 52 8 686-717
23. Kiely J L., McNicholas W T. Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 2000 16 1 128-133 (Pubitemid 30480141)
24. Aytemir K, Deniz A, Yavuz B et al. Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med 2007 101 6 1277-1282 (Pubitemid 46667665)
25. Ryan S, McNicholas W T. Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS. Arch Physiol Biochem 2008 114 4 261-266
26. Ryan S, Taylor C T., McNicholas W T. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009 64 7 631-636
27. Attal P, Chanson P. Endocrine aspects of obstructive sleep apnea. J Clin Endocrinol Metab 2010 95 2 483-495
28. Takagi T, Morser J, Gabazza E C. et al. The coagulation and protein C pathways in patients with sleep apnea. Lung 2009 187 4 209-213
29. Zamarrón C, Ricoy J, Riveiro A, Gude F. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 2008 186 3 151-156
30. Mancia G. Autonomic modulation of the cardiovascular system during sleep. N Engl J Med 1993 328 5 347-349 (Pubitemid 23035336)
31. Noda A, Yasuma F, Okada T, Yokota M. Influence of movement arousal on circadian rhythm of blood pressure in obstructive sleep apnea syndrome. J Hypertens 2000 18 5 539-544 (Pubitemid 30303483)
32. Weiss J W., Remsburg S, Garpestad E, Ringler J, Sparrow D, Parker J A. Hemodynamic consequences of obstructive sleep apnea. Sleep 1996 19 5 388-397 (Pubitemid 26256753)
33. Baguet J P., Barone-Rochette G, Pépin J L. Hypertension and obstructive sleep apnoea syndrome: current perspectives. J Hum Hypertens 2009 23 7 431-443
34. Narkiewicz K, van de Borne P J., Pesek C A., Dyken M E., Montano N, Somers V K. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999 99 9 1183-1189 (Pubitemid 29120090)
35. Gilmartin G S., Tamisier R, Curley M, Weiss J W. Ventilatory, hemodynamic, sympathetic nervous system, and vascular reactivity changes after recurrent nocturnal sustained hypoxia in humans. Am J Physiol Heart Circ Physiol 2008 295 2 H778-H785
36. Greenberg H E., Sica A, Batson D, Scharf S M. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 1999 86 1 298-305 (Pubitemid 29046970)
37. Morgan B J., Denahan T, Ebert T J. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 1993 74 6 2969-2975 (Pubitemid 23201331)
38. Sukegawa M, Noda A, Yasuda Y et al. Impact of microarousal associated with increased negative esophageal pressure in sleep-disordered breathing. Sleep Breath 2009 13 4 369-373
39. Stradling J R., Pitson D J., Bennett L, Barbour C, Davies R J. Variation in the arousal pattern after obstructive events in obstructive sleep apnea. Am J Respir Crit Care Med 1999 159 1 130-136 (Pubitemid 29036515)
40. Davies R J., Belt P J., Roberts S J., Ali N J., Stradling J R. Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol 1993 74 3 1123-1130 (Pubitemid 23118561)
41. Brooks D, Horner R L., Kozar L F., Render-Teixeira C L., Phillipson E A. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 1997 99 1 106-109 (Pubitemid 27058300)
42. Kimoff R J., Makino H, Horner R L. et al. Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol 1994 76 4 1810-1817 (Pubitemid 24125705)
43. Fletcher E C., Lesske J, Qian W, Miller C C. III, Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 1992 19 6 Pt 1 555-561
44. Guilleminault C, Connolly S, Winkle R, Melvin K, Tilkian A. Cyclical variation of the heart rate in sleep apnoea syndrome. Mechanisms, and usefulness of 24 h electrocardiography as a screening technique. Lancet 1984 1 8369 126-131 (Pubitemid 14217549)
45. Meanock C I. Influence of the vagus nerve on changes in heart rate during sleep apnoea in man. Clin Sci (Lond) 1982 62 2 163-167 (Pubitemid 12189769)
46. Hanly P J., George C F., Millar T W., Kryger M H. Heart rate response to breath-hold, Valsalva and Mueller maneuvers in obstructive sleep apnea. Chest 1989 95 4 735-739 (Pubitemid 19102875)
47. Carlson J T., Hedner J, Elam M, Ejnell H, Sellgren J, Wallin B G. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 1993 103 6 1763-1768 (Pubitemid 23174312)
48. Somers V K., Dyken M E., Clary M P., Abboud F M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995 96 4 1897-1904
49. Narkiewicz K, van de Borne P J., Cooley R L., Dyken M E., Somers V K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998 98 8 772-776 (Pubitemid 28391842)
50. Grassi G, Facchini A, Trevano F Q. et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 2005 46 2 321-325 (Pubitemid 41099164)
51. Peled N, Greenberg A, Pillar G, Zinder O, Levi N, Lavie P. Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. Am J Hypertens 1998 11 11 Pt 1 1284-1289 (Pubitemid 28541042)
52. Dimsdale J E., Coy T, Ancoli-Israel S, Mills P, Clausen J, Ziegler M G. Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality. Chest 1997 111 3 639-642 (Pubitemid 27132938)
53. Jennum P, Wildschiødtz G, Christensen N J., Schwartz T. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal Continuous Positive Airway Pressure (nCPAP) treatment. Am J Hypertens 1989 2 11 Pt 1 847-852 (Pubitemid 19267650)
54. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore M R. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993 103 3 722-727 (Pubitemid 23086163)
55. Narkiewicz K, van de Borne P J., Montano N, Dyken M E., Phillips B G., Somers V K. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 1998 97 10 943-945 (Pubitemid 28125464)
56. Narkiewicz K, Pesek C A., Kato M, Phillips B G., Davison D E., Somers V K. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension 1998 32 6 1039-1043 (Pubitemid 29001433)
57. Leuenberger U, Jacob E, Sweer L, Waravdekar N, Zwillich C, Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 1995 79 2 581-588
58. Fletcher E C. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000 119 2-3 189-197 (Pubitemid 30155574)
59. Parati G, Di Rienzo M, Bonsignore M R. et al. Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens 1997 15 12 Pt 2 1621-1626 (Pubitemid 28029655)
60. Hedner J, Darpö B, Ejnell H, Carlson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995 8 2 222-229
61. Veale D, Pépin J L., Wuyam B, Lévy P A. Abnormal autonomic stress responses in obstructive sleep apnoea are reversed by nasal continuous positive airway pressure. Eur Respir J 1996 9 10 2122-2126 (Pubitemid 26333554)
62. Narkiewicz K, Kato M, Phillips B G., Pesek C A., Davison D E., Somers V K. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999 100 23 2332-2335
63. Gjørup P H., Sadauskiene L, Wessels J, Nyvad O, Strunge B, Pedersen E B. Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease. Am J Hypertens 2007 20 1 44-52 (Pubitemid 46014056)
64. Phillips B G., Narkiewicz K, Pesek C A., Haynes W G., Dyken M E., Somers V K. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 1999 17 1 61-66 (Pubitemid 29086189)
65. Møller D S., Lind P, Strunge B, Pedersen E B. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 2003 16 4 274-280 (Pubitemid 36384754)
66. Pratt-Ubunama M N., Nishizaka M K., Boedefeld R L., Cofield S S., Harding S M., Calhoun D A. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007 131 2 453-459
67. Calhoun D A., Nishizaka M K., Zaman M A., Harding S M. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 2004 125 1 112-117 (Pubitemid 38114572)
68. Takahashi S, Nakamura Y, Nishijima T, Sakurai S, Inoue H. Essential roles of angiotensin II in vascular endothelial growth factor expression in sleep apnea syndrome. Respir Med 2005 99 9 1125-1131 (Pubitemid 41102649)
69. Svatikova A, Olson L J., Wolk R et al. Obstructive sleep apnea and aldosterone. Sleep 2009 32 12 1589-1592
70. Grassi G, Seravalle G, Quarti-Trevano F et al. Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea. J Hypertens 2010 28 6 1313-1320
71. Steiropoulos P, Papanas N, Nena E et al. Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control? Sleep Med 2009 10 8 887-891
72. Lam D C., Xu A, Lam K S. et al. Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur Respir J 2009 33 2 346-351
73. Cuhadarolu C, Utkusava A, Oztürk L, Salman S, Ece T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 2009 187 2 75-81
74. Lam J C., Xu A, Tam S et al. Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 2008 31 12 1721-1727
75. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi H K. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009 122 12 1122-1127
76. Ronksley P E., Hemmelgarn B R., Heitman S J. et al. Obstructive sleep apnoea is associated with diabetes in sleepy subjects. Thorax 2009 64 10 834-839
77. Carneiro G, Togeiro S M., Ribeiro-Filho F F. et al. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord 2009 7 6 537-542
78. Dawson A, Abel S L., Loving R T. et al. CPAP therapy of obstructive sleep apnea in type 2 diabetics improves glycemic control during sleep. J Clin Sleep Med 2008 4 6 538-542
79. Louis M, Punjabi N M. Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009 106 5 1538-1544
80. Coughlin S R., Mawdsley L, Mugarza J A., Calverley P M., Wilding J P. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004 25 9 735-741 (Pubitemid 38647933)
81. Li A M., Ng C, Ng S K. et al. Adipokines in children with obstructive sleep apnea and the effects of treatment. Chest 2010 137 3 529-535
82. Tokuda F, Sando Y, Matsui H, Koike H, Yokoyama T. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome. Intern Med 2008 47 21 1843-1849
83. Drummond M, Winck J C., Guimarães J T., Santos A C., Almeida J, Marques J A. Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients. BMC Pulm Med 2008 8 21
84. Trenell M I., Ward J A., Yee B J. et al. Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab 2007 9 5 679-687 (Pubitemid 47261849)
85. Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T. Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome. Chest 2005 127 3 716-721 (Pubitemid 40775497)
86. Shimura R, Tatsumi K, Nakamura A et al. Fat accumulation, leptin, and hypercapnia in obstructive sleep apnea-hypopnea syndrome. Chest 2005 127 2 543-549 (Pubitemid 40229315)
87. Sanner B M., Kollhosser P, Buechner N, Zidek W, Tepel M. Influence of treatment on leptin levels in patients with obstructive sleep apnoea. Eur Respir J 2004 23 4 601-604 (Pubitemid 38456004)
88. Harsch I A., Konturek P C., Koebnick C et al. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 2003 22 2 251-257 (Pubitemid 36986993)
89. Schäfer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold H K. Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 2002 122 3 829-839
90. Shimizu K, Chin K, Nakamura T et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome. Thorax 2002 57 5 429-434 (Pubitemid 34494154)
91. Ip M S., Lam K S., Ho C, Tsang K W., Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000 118 3 580-586
92. Phillips B G., Kato M, Narkiewicz K, Choe I, Somers V K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000 279 1 H234-H237 (Pubitemid 30616665)
93. Chin K, Shimizu K, Nakamura T et al. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 1999 100 7 706-712 (Pubitemid 29383639)
94. Arnardottir E S., Mackiewicz M, Gislason T, Teff K L., Pack A I. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 2009 32 4 447-470
95. Kheirandish L, Row B W., Li R C., Brittian K R., Gozal D. Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep 2005 28 11 1412-1417 (Pubitemid 41572792)
96. Prabhakar N R., Kumar G K., Nanduri J, Semenza G L. ROS signaling in systemic and cellular responses to chronic intermittent hypoxia. Antioxid Redox Signal 2007 9 9 1397-1403 (Pubitemid 47255019)
97. Row B W., Liu R, Xu W, Kheirandish L, Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med 2003 167 11 1548-1553 (Pubitemid 37363366)
98. Zhan G, Serrano F, Fenik P et al. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 2005 172 7 921-929 (Pubitemid 41369078)
99. Montgomery-Downs H E., Krishna J, Roberts L J. II, Gozal D. Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath 2006 10 4 211-215 (Pubitemid 44768848)
100. Barceló A, Barbé F, de la Peña M et al. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 2006 27 4 756-760 (Pubitemid 44914199)
101. Carpagnano G E., Kharitonov S A., Resta O, Foschino-Barbaro M P., Gramiccioni E, Barnes P J. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 2003 124 4 1386-1392 (Pubitemid 37290049)
102. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002 165 7 934-939 (Pubitemid 34774660)
103. Jordan W, Cohrs S, Degner D et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 2006 113 2 239-254 (Pubitemid 43121759)
104. Schulz R, Mahmoudi S, Hattar K et al. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 2000 162 2 Pt 1 566-570 (Pubitemid 30647201)
105. Yamauchi M, Nakano H, Maekawa J et al. Oxidative stress in obstructive sleep apnea. Chest 2005 127 5 1674-1679 (Pubitemid 46218794)
106. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 2008 134 4 686-692
107. de Lima A M., Franco C M., de Castro C M., Bezerra A D., Atade L, Halpern A. Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 2009; July 3 (Epub ahead of print)
108. Gozal D, Serpero L D., Sans Capdevila O, Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 2008 9 3 254-259 (Pubitemid 351387097)
109. Punjabi N M., Beamer B A. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep 2007 30 1 29-34 (Pubitemid 46095380)
110. Tauman R, O'Brien L M., Gozal D. Hypoxemia and obesity modulate plasma C-reactive protein and interleukin-6 levels in sleep-disordered breathing. Sleep Breath 2007 11 2 77-84 (Pubitemid 46745859)
111. Ursava A, Karada M, Rodoplu E, Yilmaztepe A, Oral H B., Gözü R O. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 2007 74 5 525-532 (Pubitemid 47206882)
112. Kobayashi K, Nishimura Y, Shimada T et al. Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest 2006 129 3 632-637
113. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005 1051 340-350 (Pubitemid 41362764)
114. Minoguchi K, Tazaki T, Yokoe T et al. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 2004 126 5 1473-1479 (Pubitemid 39525019)
115. Ciftci T U., Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004 28 2 87-91 (Pubitemid 39302489)
116. Teramoto S, Yamamoto H, Ouchi Y. Increased plasma interleukin-6 is associated with the pathogenesis of obstructive sleep apnea syndrome. Chest 2004 125 5 1964-1965 author reply 1965 (Pubitemid 38648441)
117. Thomopoulos C, Tsioufis C, Dimitriadis K et al. Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. J Hum Hypertens 2009 23 1 65-67
118. Arias M A., García-Río F, Alonso-Fernández A et al. CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 2008 32 4 1009-1015
119. Sahlman J, Miettinen K, Peuhkurinen K et al, Kuopio Sleep Apnoea Group. The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res 2010 19 2 341-348
120. Tamaki S, Yamauchi M, Fukuoka A et al. Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med 2009 48 15 1255-1262
121. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002 165 1 67-70 (Pubitemid 34053359)
122. Imagawa S, Yamaguchi Y, Higuchi M et al. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apneahypopnea syndrome. Blood 2001 98 4 1255-1257
123. Teramoto S, Kume H, Yamamoto H et al. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med 2003 42 8 681-685 (Pubitemid 37021199)
124. Kähler C M., Wechselberger J, Molnar C, Prior C. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia. Am J Respir Crit Care Med 2003 167 1 92-93 author reply 93 (Pubitemid 36015926)
125. Gozal D, Lipton A J., Jones K L. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 2002 25 1 59-65 (Pubitemid 34072660)
126. Gunsilius E, Petzer A L., Gastl G A. Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome. Blood 2002 99 1 393-394
127. Kohler M, Ayers L, Pepperell J C. et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 2009 64 1 67-73
128. Vgontzas A N., Zoumakis E, Bixler E O. et al. Selective effects of CPAP on sleep apnoea-associated manifestations. Eur J Clin Invest 2008 38 8 585-595 (Pubitemid 352019140)
129. Vgontzas A N., Zoumakis E, Lin H M., Bixler E O., Trakada G, Chrousos G P. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004 89 9 4409-4413 (Pubitemid 39244447)
130. Barceló A, de la Peña M, Ayllón O et al. Increased plasma levels of asymmetric dimethylarginine and soluble CD40 ligand in patients with sleep apnea. Respiration 2009 77 1 85-90
131. Akinnusi M E., Paasch L L., Szarpa K R., Wallace P K., El Solh A A. Impact of nasal continuous positive airway pressure therapy on markers of platelet activation in patients with obstructive sleep apnea. Respiration 2009 77 1 25-31
132. Cox D, Bradford A. Continuous positive airway pressure and platelet activation in obstructive sleep apnoea. Respiration 2009 77 1 18-20
133. Kraiczi H, Caidahl K, Samuelsson A, Peker Y, Hedner J. Impairment of vascular endothelial function and left ventricular filling: association with the severity of apnea-induced hypoxemia during sleep. Chest 2001 119 4 1085-1091 (Pubitemid 32679435)
134. Kato M, Roberts-Thomson P, Phillips B G. et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 2000 102 21 2607-2610
135. Oflaz H, Cuhadaroglu C, Pamukcu B et al. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 2006 73 6 751-756 (Pubitemid 44795920)
136. Tanriverdi H, Evrengul H, Kara C O. et al. Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 2006 73 6 741-750 (Pubitemid 44795919)
137. Gozal D, Kheirandish-Gozal L, Serpero L D., Sans Capdevila O, Dayyat E. Obstructive sleep apnea and endothelial function in school-aged nonobese children: effect of adenotonsillectomy. Circulation 2007 116 20 2307-2314 (Pubitemid 350100337)
138. Chung S, Yoon I Y., Shin Y K. et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep 2007 30 8 997-1001 (Pubitemid 47221900)
139. Carlson J T., Rångemark C, Hedner J A. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens 1996 14 5 577-584 (Pubitemid 26161112)
140. Duchna H W., Orth M, Schultze-Werninghaus G, Guilleminault C, Stoohs R A. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome. Sleep Breath 2005 9 3 97-103 (Pubitemid 44193439)
141. Cross M D., Mills N L., Al-Abri M et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomised controlled trial. Thorax 2008 63 7 578-583 (Pubitemid 351969249)
142. Ohike Y, Kozaki K, Iijima K et al. Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressurepossible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine. Circ J 2005 69 2 221-226 (Pubitemid 40313045)
143. Lattimore J L., Wilcox I, Skilton M, Langenfeld M, Celermajer D S. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 2006 61 6 491-495 (Pubitemid 43901518)
144. Comondore V R., Cheema R, Fox J et al. The impact of CPAP on cardiovascular biomarkers in minimally symptomatic patients with obstructive sleep apnea: a pilot feasibility randomized crossover trial. Lung 2009 187 1 17-22
145. Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 2007 131 3 740-749 (Pubitemid 46446865)
146. Duchna H W., Orth M, Schultze-Werninghaus G, Guilleminault C, Stoohs R A. Antihypertensive treatment and endothelium-dependent venodilation in sleep-disordered breathing. Sleep Breath 2006 10 3 115-122 (Pubitemid 44322492)
147. Grebe M, Eisele H J., Weissmann N et al. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 2006 173 8 897-901
148. El Solh A A., Saliba R, Bosinski T, Grant B J., Berbary E, Miller N. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006 27 5 997-1002 (Pubitemid 44911115)
149. Zhong X, Xiao Y, Basner R C. Effects of antihypertensives on arterial responses associated with obstructive sleep apneas. Chin Med J (Engl) 2005 118 2 123-129 (Pubitemid 40227804)
150. Protogerou A D., Laaban J P., Czernichow S et al. Structural and functional arterial properties in patients with obstructive sleep apnoea syndrome and cardiovascular comorbidities. J Hum Hypertens 2008 22 6 415-422 (Pubitemid 351712388)
151. Kohler M, Craig S, Nicoll D, Leeson P, Davies R J., Stradling J R. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med 2008 178 9 984-988
152. Drager L F., Diegues-Silva L, Diniz P M. et al. Obstructive sleep apnea, masked hypertension, and arterial stiffness in men. Am J Hypertens 2010 23 3 249-254
153. Suzuki T, Nakano H, Maekawa J et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004 27 1 129-133 (Pubitemid 43906324)
154. Baguet J P., Hammer L, Lévy P et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005 128 5 3407-3412 (Pubitemid 41698671)
155. Minoguchi K, Yokoe T, Tazaki T et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005 172 5 625-630 (Pubitemid 41232975)
156. Drager L F., Bortolotto L A., Krieger E M., Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 2009 53 1 64-69
157. Lavie L, Perelman A, Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 2001 120 3 900-908 (Pubitemid 32885467)
158. Ozkan Y, Firat H, Simek B, Torun M, Yardim-Akaydin S. Circulating nitric oxide (NO), asymmetric dimethylarginine (ADMA), homocysteine, and oxidative status in obstructive sleep apnea-hypopnea syndrome (OSAHS). Sleep Breath 2008 12 2 149-154 (Pubitemid 351486675)
159. Takagi T, Morser J, Gabazza E C. et al. The coagulation and protein C pathways in patients with sleep apnea. Lung 2009 187 4 209-213
160. von Känel R, Le D T., Nelesen R A., Mills P J., Ancoli-Israel S, Dimsdale J E. The hypercoagulable state in sleep apnea is related to comorbid hypertension. J Hypertens 2001 19 8 1445-1451 (Pubitemid 32730462)
161. von Känel R, Loredo J S., Ancoli-Israel S, Dimsdale J E. Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure. Sleep Breath 2006 10 3 139-146 (Pubitemid 44322495)
162. von Känel R, Loredo J S., Powell F L., Adler K A., Dimsdale J E. Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin Hemorheol Microcirc 2005 33 4 369-377 (Pubitemid 41750562)
163. Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer B E. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 2005 104 2 92-96 (Pubitemid 41197018)
164. Ishikawa J, Hoshide S, Eguchi K et al. Increased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome. J Hypertens 2008 26 6 1181-1187 (Pubitemid 351670510)
165. Zamarrón C, Ricoy J, Riveiro A, Gude F. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung 2008 186 3 151-156
166. Riha R L. Genetic aspects of the obstructive sleep apnoea/hypopnoea syndromeis there a common link with obesity? Respiration 2009 78 1 5-17
167. Doi M, Takahashi Y, Komatsu R et al. Salt-sensitive hypertension in circadian clock-deficient Cry-null mice involves dysregulated adrenal Hsd3b6. Nat Med 2010 16 1 67-74
168. Portaluppi F, Provini F, Cortelli P et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens 1997 15 11 1227-1233 (Pubitemid 27453174)
169. Stoohs R A., Gingold J, Cohrs S, Harter R, Finlayson E, Guilleminault C. Sleep-disordered breathing and systemic hypertension in the older male. J Am Geriatr Soc 1996 44 11 1295-1300 (Pubitemid 26374804)
170. Fletcher E C., DeBehnke R D., Lovoi M S., Gorin A B. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985 103 2 190-195 (Pubitemid 15000567)
171. Logan A G., Perlikowski S M., Mente A et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001 19 12 2271-2277 (Pubitemid 33135251)
172. Gonçalves S C., Martinez D, Gus M et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest 2007 132 6 1858-1862
173. Chobanian A V., Bakris G L., Black H R. et al, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003 42 6 1206-1252 (Pubitemid 37553153)
174. Tishler P V., Larkin E K., Schluchter M D., Redline S. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 2003 289 17 2230-2237 (Pubitemid 37430191)
175. Newman A B., Foster G, Givelber R, Nieto F J., Redline S, Young T. Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005 165 20 2408-2413 (Pubitemid 41640854)
176. Nieto F J., Young T B., Lind B K. et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000 283 14 1829-1836 (Pubitemid 30207619)
177. O'Connor G T., Caffo B, Newman A B. et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009 179 12 1159-1164
178. Peppard P E., Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000 342 19 1378-1384 (Pubitemid 30262394)
179. Bixler E O., Vgontzas A N., Lin H M. et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000 160 15 2289-2295
180. Haas D C., Foster G L., Nieto F J. et al. Age-dependent associations between sleep-disordered breathing and hypertension: importance of discriminating between systolic/diastolic hypertension and isolated systolic hypertension in the Sleep Heart Health Study. Circulation 2005 111 5 614-621 (Pubitemid 40216489)
181. Bixler E O., Vgontzas A N., Lin H M. et al. Blood pressure associated with sleep-disordered breathing in a population sample of children. Hypertension 2008 52 5 841-846
182. Davies C W., Crosby J H., Mullins R L., Barbour C, Davies R J., Stradling J R. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000 55 9 736-740 (Pubitemid 30660899)
183. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure dipping and non-dipping in obstructive sleep apnea syndrome patients. Sleep 1996 19 5 382-387 (Pubitemid 26256752)
184. Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J Hypertens Suppl 1994 12 5 S13-S21 (Pubitemid 24245344)
185. Ancoli-Israel S, Stepnowsky C, Dimsdale J, Marler M, Cohen-Zion M, Johnson S. The effect of race and sleep-disordered breathing on nocturnal BP dipping: analysis in an older population. Chest 2002 122 4 1148-1155 (Pubitemid 35339523)
186. Noda A, Okada T, Hayashi H, Yasuma F, Yokota M. 24-hour ambulatory blood pressure variability in obstructive sleep apnea syndrome. Chest 1993 103 5 1343-1347 (Pubitemid 23145582)
187. Baguet J-P, Lévy P, Barone-Rochette G et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 2008 26 5 885-892 (Pubitemid 351520975)
188. Narkiewicz K, Montano N, Cogliati C, van de Borne P J., Dyken M E., Somers V K. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998 98 11 1071-1077 (Pubitemid 28420698)
189. Baguet J-P, Hammer L, Lévy P et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005 23 3 521-527 (Pubitemid 40684709)
190. Barbé F, Mayoralas L R., Duran J et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med 2001 134 11 1015-1023 (Pubitemid 32488655)
191. Barnes M, Houston D, Worsnop C J. et al. A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 2002 165 6 773-780 (Pubitemid 34229646)
192. Becker H F., Jerrentrup A, Ploch T et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003 107 1 68-73 (Pubitemid 36070935)
193. Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006 129 6 1459-1467 (Pubitemid 43894973)
194. Coughlin S R., Mawdsley L, Mugarza J A., Wilding J P., Calverley P M. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 2007 29 4 720-727 (Pubitemid 46554622)
195. Dimsdale J E., Loredo J S., Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000 35 1 Pt 1 144-147 (Pubitemid 30054251)
196. Faccenda J F., Mackay T W., Boon N A., Douglas N J. Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. Am J Respir Crit Care Med 2001 163 2 344-348 (Pubitemid 32158510)
197. Norman D, Loredo J S., Nelesen R A. et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006 47 5 840-845 (Pubitemid 44297553)
198. Pepperell J C., Ramdassingh-Dow S, Crosthwaite N et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002 359 9302 204-210 (Pubitemid 34113817)
199. Robinson G V., Smith D M., Langford B A., Davies R J., Stradling J R. Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients. Eur Respir J 2006 27 6 1229-1235 (Pubitemid 44914309)
200. Usui K, Bradley T D., Spaak J et al. Inhibition of awake sympathetic nerve activity of heart failure patients with obstructive sleep apnea by nocturnal continuous positive airway pressure. J Am Coll Cardiol 2005 45 12 2008-2011 (Pubitemid 40814123)
201. Arias M A., García-Río F, Alonso-Fernández A, Mediano O, Martínez I, Villamor J. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005 112 3 375-383 (Pubitemid 41022078)
202. Barnes M, McEvoy R D., Banks S et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004 170 6 656-664 (Pubitemid 39202208)
203. Engleman H M., Gough K, Martin S E., Kingshott R N., Padfield P L., Douglas N J. Ambulatory blood pressure on and off continuous positive airway pressure therapy for the sleep apnea/hypopnea syndrome: effects in non-dippers Sleep 1996 19 5 378-381 (Pubitemid 26256751)
204. Ip M S., Tse H F., Lam B, Tsang K W., Lam W K. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 2004 169 3 348-353 (Pubitemid 38134813)
205. Kaneko Y, Floras J S., Usui K et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003 348 13 1233-1241 (Pubitemid 36359299)
206. Mansfield D R., Gollogly N C., Kaye D M., Richardson M, Bergin P, Naughton M T. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004 169 3 361-366 (Pubitemid 38134815)
207. Mills P J., Kennedy B P., Loredo J S., Dimsdale J E., Ziegler M G. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol 2006 100 1 343-348 (Pubitemid 43671127)
208. Alajmi M, Mulgrew A T., Fox J et al. Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials. Lung 2007 185 2 67-72 (Pubitemid 46571874)
209. Haentjens P, Van Meerhaeghe A, Moscariello A et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 2007 167 8 757-764
210. Bazzano L A., Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 2007 50 2 417-423 (Pubitemid 47205794)
211. Akashiba T, Minemura H, Yamamoto H, Kosaka N, Saito O, Horie T. Nasal continuous positive airway pressure changes blood pressure non-dippers to dippers in patients with obstructive sleep apnea. Sleep 1999 22 7 849-853 (Pubitemid 29526505)
212. Hermida R C., Zamarrón C, Ayala D E., Calvo C. Effect of continuous positive airway pressure on ambulatory blood pressure in patients with obstructive sleep apnoea. Blood Press Monit 2004 9 4 193-202 (Pubitemid 39159162)
213. Gotsopoulos H, Kelly J J., Cistulli P A. Oral appliance therapy reduces blood pressure in obstructive sleep apnea: a randomized, controlled trial. Sleep 2004 27 5 934-941 (Pubitemid 39095726)
214. Kraiczi H, Hedner J, Peker Y, Grote L. Comparison of atenolol, amlodipine, enalapril, hydrochlorothiazide, and losartan for antihypertensive treatment in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2000 161 5 1423-1428 (Pubitemid 30329007)
215. Wustmann K, Kucera J P., Scheffers I et al. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension 2009 54 3 530-536
216. Arzt M, Young T, Finn L, Skatrud J B., Bradley T D. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005 172 1447-1451 (Pubitemid 43069819)
217. Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health 2006 60 1 69-73 (Pubitemid 43028633)
218. Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil 1995 76 1 71-76
219. Dyken M E., Somers V K., Yamada T, Ren Z Y., Zimmerman M B. Investigating the relationship between stroke and obstructive sleep apnea. Stroke 1996 27 3 401-407 (Pubitemid 26081432)
220. Shahar E, Whitney C W., Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001 163 1 19-25 (Pubitemid 32095247)
221. Good D C., Henkle J Q., Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke 1996 27 2 252-259 (Pubitemid 26044496)
222. Sahlin C, Sandberg O, Gustafson Y et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008 168 3 297-301 (Pubitemid 351281676)
223. Palomäki H. Snoring and the risk of ischemic brain infarction. Stroke 1991 22 8 1021-1025
224. Neau J-Ph, Meurice J C., Paquereau J, Chavagnat J J., Ingrand P, Gil R. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand 1995 92 1 63-68
225. Askenasy J JM, Goldhammer I. Sleep apnea as a feature of bulbar stroke. Stroke 1988 19 5 637-639
226. Bogousslavsky J, Khurana R, Deruaz J P. et al. Respiratory failure and unilateral caudal brainstem infarction. Ann Neurol 1990 28 5 668-673 (Pubitemid 20373901)
227. Droste D W., Lüdemann P, Anders F et al. Middle cerebral artery blood flow velocity, end-tidal pCO2 and blood pressure in patients with obstructive sleep apnea and in healthy subjects during continuous positive airway pressure breathing. Neurol Res 1999 21 8 737-741
228. Diomedi M, Placidi F, Cupini L M., Bernardi G, Silvestrini M. Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment. Neurology 1998 51 4 1051-1056 (Pubitemid 28473399)
229. Hajak G, Klingelhöfer J, Schulz-Varszegi M, Sander D, Rüther E. Sleep apnea syndrome and cerebral hemodynamics. Chest 1996 110 3 670-679 (Pubitemid 27009290)
230. Dikmenolu N, Ciftçi B, Ileri E et al. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med 2006 7 3 255-261
231. Furtner M, Staudacher M, Frauscher B et al. Cerebral vasoreactivity decreases overnight in severe obstructive sleep apnea syndrome: a study of cerebral hemodynamics. Sleep Med 2009 10 8 875-881
232. Altin R, Ozdemir H, Mahmutyaziciolu K et al. Evaluation of carotid artery wall thickness with high-resolution sonography in obstructive sleep apnea syndrome. J Clin Ultrasound 2005 33 2 80-86 (Pubitemid 40194417)
233. Beelke M, Angeli S, Del Sette M et al. Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med 2003 4 3 219-223 (Pubitemid 36748607)
234. Wessendorf T E., Thilmann A F., Wang Y M., Schreiber A, Konietzko N, Teschler H. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000 162 6 2039-2042 (Pubitemid 32051660)
235. Geiser T, Buck F, Meyer B J., Bassetti C, Haeberli A, Gugger M. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002 69 3 229-234 (Pubitemid 34827837)
236. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995 108 3 625-630
237. Hedner J, Carlson J, Rangemark C, Gleerup G, Wither K. Platelet function and fibrinolytic activity in patients with sleep apnoea. J Sleep Res 1994 3 Suppl 1 101
238. Sandberg O, Franklin K A., Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J 2001 18 4 630-634 (Pubitemid 33040620)
239. Hsu C Y., Vennelle M, Li H Y., Engleman H M., Dennis M S., Douglas N J. Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatry 2006 77 10 1143-1149 (Pubitemid 44453248)
240. Shaw J E., Punjabi N M., Wilding J P., Alberti K G., Zimmet P Z., International Diabetes Federation Taskforce on Epidemiology and Prevention. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes Res Clin Pract 2008 81 1 2-12 (Pubitemid 351778429)
241. Keckeis M, Lattova Z, Maurovich-Horvat E et al. Impaired glucose tolerance in sleep disorders. PLoS ONE 2010 5 3 e9444
242. Punjabi N M., Shahar E, Redline S, Gottlieb D J., Givelber R, Resnick H E., Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004 160 6 521-530 (Pubitemid 39215628)
243. Punjabi N M., Beamer B A. Alterations in Glucose Disposal in Sleep-disordered Breathing. Am J Respir Crit Care Med 2009 179 3 235-240
244. Aronsohn R S., Whitmore H, Van Cauter E, Tasali E. Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010 181 5 507-513
245. Otake K, Sasanabe R, Hasegawa R et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med 2009 48 21 1863-1868
246. Mahmood K, Akhter N, Eldeirawi K et al. Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample. J Clin Sleep Med 2009 5 3 215-221
247. Meslier N, Gagnadoux F, Giraud P et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 2003 22 1 156-160 (Pubitemid 36896486)
248. Levinson P D., McGarvey S T., Carlisle C C., Eveloff S E., Herbert P N., Millman R P. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest 1993 103 5 1336-1342 (Pubitemid 23145581)
249. Grunstein R R., Stenlöf K, Hedner J, Sjöström L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obes Relat Metab Disord 1995 19 6 410-418
250. Reichmuth K J., Austin D, Skatrud J B., Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005 172 12 1590-1595 (Pubitemid 43076551)
251. Polotsky V Y., Li J, Punjabi N M. et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003 552 Pt 1 253-264 (Pubitemid 37265483)
252. Tasali E, Leproult R, Ehrmann D A., Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A 2008 105 3 1044-1049 (Pubitemid 351282078)
253. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005 99 5 2008-2019 (Pubitemid 41547204)
254. Hatipolu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003 70 6 665-671 (Pubitemid 38142324)
255. West S D., Nicoll D J., Wallace T M., Matthews D R., Stradling J R. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007 62 11 969-974 (Pubitemid 350084496)
256. Babu A R., Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005 165 4 447-452 (Pubitemid 40280202)
257. Pallayova M, Donic V, Tomori Z. Beneficial effects of severe sleep apnea therapy on nocturnal glucose control in persons with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008 81 1 e8-e11
258. Yee B, Liu P, Phillips C, Grunstein R. Neuroendocrine changes in sleep apnea. Curr Opin Pulm Med 2004 10 6 475-481 (Pubitemid 39441440)
259. Luboshitzky R, Aviv A, Hefetz A et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab 2002 87 7 3394-3398 (Pubitemid 34816395)
260. Gambineri A, Pelusi C, Pasquali R. Testosterone levels in obese male patients with obstructive sleep apnea syndrome: relation to oxygen desaturation, body weight, fat distribution and the metabolic parameters. J Endocrinol Invest 2003 26 6 493-498 (Pubitemid 36998695)
261. Netzer N C., Eliasson A H., Strohl K P. Women with sleep apnea have lower levels of sex hormones. Sleep Breath 2003 7 1 25-29 (Pubitemid 36553402)
262. Lanfranco F, Gianotti L, Pivetti S et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol (Oxf) 2004 60 1 41-48 (Pubitemid 38183496)
263. Punjabi N M., Polotsky V Y. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005 99 5 1998-2007 (Pubitemid 41547203)
264. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006 28 3 596-602 (Pubitemid 44794676)
265. Franklin K A., Nilsson J B., Sahlin C, Näslund U. Sleep apnoea and nocturnal angina. Lancet 1995 345 8957 1085-1087
266. Hung J, Whitford E G., Parsons R W., Hillman D R. Association of sleep apnoea with myocardial infarction in men. Lancet 1990 336 8710 261-264 (Pubitemid 20229120)
267. Schäfer H, Koehler U, Ewig S, Hasper E, Tasci S, Lüderitz B. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology 1999 92 2 79-84 (Pubitemid 30135935)
268. Mooe T, Rabben T, Wiklund U, Franklin K A., Eriksson P. Sleep-disordered breathing in men with coronary artery disease. Chest 1996 109 3 659-663 (Pubitemid 26086931)
269. Aboyans V, Cassat C, Lacroix P et al. Is the morning peak of acute myocardial infarction's onset due to sleep-related breathing disorders? A prospective study. Cardiology 2000 94 3 188-192 (Pubitemid 32250149)
270. Sorajja D, Gami A S., Somers V K., Behrenbeck T R., Garcia-Touchard A, Lopez-Jimenez F. Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 2008 133 4 927-933 (Pubitemid 351536868)
271. Lee C H., Khoo S M., Tai B C. et al. Obstructive sleep apnea in patients admitted for acute myocardial infarction. Prevalence, predictors, and effect on microvascular perfusion. Chest 2009 135 6 1488-1495
272. Peker Y, Hedner J, Kraiczi H, Löth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000 162 1 81-86 (Pubitemid 30469802)
273. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007 99 1 26-30 (Pubitemid 44969334)
274. Steiner S, Schueller P O., Hennersdorf M G., Behrendt D, Strauer B E. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res 2008 9 50
275. Nakashima H, Katayama T, Takagi C et al. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 2006 27 19 2317-2322 (Pubitemid 44453575)
276. Turmel J, Sériès F, Boulet L P. et al. Relationship between atherosclerosis and the sleep apnea syndrome: an intravascular ultrasound study. Int J Cardiol 2009 132 2 203-209
277. Gami A S., Rader S, Svatikova A et al. Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest 2007 131 1 118-121 (Pubitemid 46122982)
278. Belaidi E, Joyeux-Faure M, Ribuot C, Launois S H., Levy P, Godin-Ribuot D. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 2009 53 15 1309-1317
279. Kuniyoshi F H., Garcia-Touchard A, Gami A S. et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008 52 5 343-346 (Pubitemid 352001344)
280. Cassar A, Morgenthaler T I., Lennon R J., Rihal C S., Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 2007 50 14 1310-1314 (Pubitemid 47446092)
281. Milleron O, Pillière R, Foucher A et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004 25 9 728-734 (Pubitemid 38647932)
282. Doherty L S., Kiely J L., Swan V, McNicholas W T. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005 127 6 2076-2084
283. Peled N, Abinader E G., Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 1999 34 6 1744-1749
284. Harbison J, O'Reilly P, McNicholas W T. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000 118 3 591-595
285. Gami A S., Somers V K. Implications of obstructive sleep apnea for atrial fibrillation and sudden cardiac death. J Cardiovasc Electrophysiol 2008 19 9 997-1003
286. Roche F, Gaspoz J M., Court-Fortune I et al. Alteration of QT rate dependence reflects cardiac autonomic imbalance in patients with obstructive sleep apnea syndrome. Pacing Clin Electrophysiol 2003 26 7 Pt 1 1446-1453 (Pubitemid 36836694)
287. Szymanowska K, Piatkowska A, Nowicka A, Cofta S, Wierzchowiecki M. Heart rate turbulence in patients with obstructive sleep apnea syndrome. Cardiol J 2008 15 5 441-445
288. Gillis A M., Stoohs R, Guilleminault C. Changes in the QT interval during obstructive sleep apnea. Sleep 1991 14 4 346-350
289. Ito R, Hamada H, Yokoyama A et al. Successful treatment of obstructive sleep apnea syndrome improves autonomic nervous system dysfunction. Clin Exp Hypertens 2005 27 2-3 259-267 (Pubitemid 40478354)
290. Nakamura T, Chin K, Hosokawa R et al. Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome. Chest 2004 125 6 2107-2114 (Pubitemid 38788177)
291. Roche F, Barthélémy J C., Garet M, Duverney D, Pichot V, Sforza E. Continuous positive airway pressure treatment improves the QT rate dependence adaptation of obstructive sleep apnea patients. Pacing Clin Electrophysiol 2005 28 8 819-825 (Pubitemid 41648224)
292. Aytemir K, Deniz A, Yavuz B et al. Increased myocardial vulnerability and autonomic nervous system imbalance in obstructive sleep apnea syndrome. Respir Med 2007 101 6 1277-1282 (Pubitemid 46667665)
293. Guilleminault C, Connolly S J., Winkle R A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983 52 5 490-494 (Pubitemid 13049175)
294. Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994 106 2 466-471 (Pubitemid 24252045)
295. Mehra R, Benjamin E J., Shahar E et al, Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006 173 8 910-916
296. Fuster V, Rydén L E., Cannom D S. et al, American College of Cardiology/American Heart Association Task Force on Practice Guidelines European Society of Cardiology Committee for Practice Guidelines European Heart Rhythm Association Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006 114 7 e257-e354 (Pubitemid 44252297)
297. Chen P S., Douglas P. Douglas P. Zipes Lecture. Neural mechanisms of atrial fibrillation. Heart Rhythm 2006 3 11 1373-1377
298. Asirvatham S J., Kapa S. Sleep apnea and atrial fibrillation: the autonomic link. J Am Coll Cardiol 2009 54 22 2084-2086
299. Kanagala R, Murali N S., Friedman P A. et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003 107 20 2589-2594 (Pubitemid 36628941)
300. Abe H, Takahashi M, Yaegashi H et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels 2010 25 1 63-69
301. Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest 1982 69 6 1286-1292 (Pubitemid 12081056)
302. Ji K H., Kim D H., Yun C H. Severe obstructive sleep apnea syndrome with symptomatic daytime bradyarrhythmia. J Clin Sleep Med 2009 5 3 246-247
303. Grimm W, Koehler U, Fus E et al. Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. Am J Cardiol 2000 86 6 688-692, A9
304. Javaheri S, Parker T J., Liming J D. et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998 97 21 2154-2159 (Pubitemid 28262123)
305. Sin D D., Fitzgerald F, Parker J D., Newton G, Floras J S., Bradley T D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999 160 4 1101-1106 (Pubitemid 29487445)
306. Wang H, Parker J D., Newton G E. et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007 49 15 1625-1631 (Pubitemid 46551635)
307. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990 8 10 941-946 (Pubitemid 20368617)
308. Laaban J P., Pascal-Sebaoun S, Bloch E, Orvoën-Frija E, Oppert J M., Huchon G. Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002 122 4 1133-1138 (Pubitemid 35339521)
309. Tkacova R, Rankin F, Fitzgerald F S., Floras J S., Bradley T D. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998 98 21 2269-2275 (Pubitemid 28533845)
310. Chen L, Shi Q, Scharf S M. Hemodynamic effects of periodic obstructive apneas in sedated pigs with congestive heart failure. J Appl Physiol 2000 88 3 1051-1060 (Pubitemid 30154911)